Concepedia
Statistics
Publications
5
Citations
170
H-Index
Active since
2009
Affiliations
University of Birmingham(Current)
RMIT University
David Jarrom is an author at University of Birmingham specializing in public health, covid-19 epidemiology, and risk.
Top concepts
RiskCovid-19MedicineVirologyDiagnosisVaccinationEpidemiologyPublic HealthVaccine EfficacyEmergency Medicine
Publications per year
2009–2022
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
Simon O. Vass, David Jarrom, William R. Wilson et al. · British Journal of Cancer · 2009 · 69 citations · Full text
Steady-State and Stopped-Flow Kinetic Studies of Three <i>Escherichia coli</i> NfsB Mutants with Enhanced Activity for the Prodrug CB1954
David Jarrom, Mansooreh Jaberipour, Christopher P. Guise et al. · Biochemistry · 2009 · 39 citations
The structures of <i>E. coli</i> NfsA bound to the antibiotic nitrofurantoin; to 1,4-benzoquinone and to FMN
Martin A. Day, David Jarrom, Andrew J. Christofferson et al. · Biochemical Journal · 2021 · 27 citations · Full text
The effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review
David Jarrom, Lauren Elston, Jennifer Washington et al. · 2020 · 20 citations · Full text
Virus Epidemiology, Viral Diagnostics, Diagnosis +17
The <scp>3D</scp>‐structure, kinetics and dynamics of the <i>E. coli</i> nitroreductase <scp>NfsA</scp> with <scp>NADP</scp><sup>+</sup> provide glimpses of its catalytic mechanism
Scott A. White, Andrew J. Christofferson, Alastair I. Grainger et al. · FEBS Letters · 2022 · 15 citations · Full text
1–5 of 5